|
⚲
|
| Origin Biomed Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001407422 |
| Sale | 2009-04-21 ($4.0 M Offered, $3.3 M Sold) |
| Fund | |
| Phone | 9024235745 |
| Address | 5162 Duke Str Halifax, B3J 1N7 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Murray McLaughlin | |
| Peter Macneil | |
| Aki Georgacacos | |
| Robert Cervelli | |
| Ron Mitton | |
| Gordon Buchan | |
| Barry Tuner |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Eng Julie Sheridan
✚
|
0.0 | |
|
RU-0117 Gaingels Fund II, a series of Zachary Ginsburg Funds
✚
|
0.0 | |
|
RU-0130 Fund I, a series of Roll Up Vehicles, LP
✚
|
0.0 | |
|
RU-0201 Fund I, a series of F2F Investments, LP
✚
|
0.0 | |
|
Hiatt's Chair Saver, Inc.
✚
|
0.0 | |
|
Hibiscus Capital Management Fund II LP
✚
|
0.0 | |
|
Hicap Jiffy Spring, LLC
✚
|
0.0 | |
|
Hickey Thomas D
✚
|
0.0 | |
|
Engage3 Holdings, Inc.
✚
|
0.0 | |
|
Biopharma Capital Limited
✚
|
0.0 |